Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition
Closed Posted
- Opportunity number
- EDS-EDS-26-001
- Agency
-
Office of the National Drug Control Policy
Executive Office of the President
- Applications due
- Award size
- Up to $500,000
Opportunity facts
- Assistance listings
-
- 95.007 Research and Data Analysis
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- Points of contact
-
- <Unknown> support@grants.gov (800) 518-4726
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Executive Office of the President Office of the National Drug Control Policy is soliciting applications for a cooperative agreement to fund research on nonfatal overdoses in emergency departments, with applications due August 31, 2026. Eligible applicants are 501(c)(3) nonprofits and public higher education institutions; applicants must demonstrate expert knowledge and extensive experience in drug research and data analysis.
The research will build local and national drug consumption surveillance capacity, identify gaps in existing drug testing protocols, facilitate information exchange across public health and public safety organizations, and support coordinated response to the drug crisis. Work includes re-testing biological specimens from emergency departments for emerging drug detection and analyzing drug supply composition alongside patient characteristics.
The cooperative agreement will be available for 12 months with possible extensions. Recent awards under CFDA 95.007 (Research and Data Analysis) range from under $100 thousand to $1.2 million, with recent cooperative agreements typically between $150 thousand and $700 thousand. Applications must not only propose research activities but also demonstrate the applicant organization's existing expertise and experience in drug research and data analysis; applications failing to demonstrate this expertise will not be considered.
Grantees must maintain complete records on fund disposition and retain grant-related records for three years. Audits conducted under 2 C.F.R. 200, Subpart F must be submitted to the Federal Audit Clearinghouse no later than nine months after the close of the recipient's audited fiscal year. ONDCP will send award and conditions electronically upon approval.
Synopsis
This research project will help build local and national drug consumption surveillance, identify gaps in existing drug testing protocols, facilitate information exchange across public health and public safety organizations, and help coordinate an informed response to address the drug crisis.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity